GlassScriptPhysician profile
Mary Caitlin St Clair
NPI 1699137745
$1,416.57
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $519 · 2021: $349 · 2022: $140 · 2023: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $120.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $291.98 | 2019-2021 | |
| Novo Nordisk INC | $220.64 | 2020-2022 | |
| Eisai INC. | $124.80 | 2020-2021 | |
| Dexcom, INC. | $120.00 | 2023 | Dexcom G7 Gss (161) |
| Astrazeneca Pharmaceuticals LP | $91.59 | 2019-2021 | |
| Abbvie INC. | $73.36 | 2021-2022 | |
| Adlon Therapeutics L.P. | $49.56 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $40.23 | 2021 | |
| Zealand Pharma US, INC. | $38.43 | 2020 | |
| Bausch Health US, LLC | $35.64 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.06 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.31 | 2020-2021 | |
| Lilly USA, LLC | $30.85 | 2021 | |
| Avanir Pharmaceuticals, INC. | $27.05 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $25.47 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $24.75 | 2022 | |
| Neos Therapeutics, LP | $19.59 | 2019 | |
| Pfizer INC. | $17.85 | 2021 | |
| Gilead Sciences, INC. | $17.51 | 2020 | |
| Therapeuticsmd, INC. | $16.02 | 2020 | |
| Medtronic USA, INC. | $15.55 | 2020 | |
| Glaxosmithkline, LLC. | $14.70 | 2021 | |
| Cranial Technologies, INC | $14.33 | 2020 | |
| Antares Pharma, INC. | $14.11 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $13.47 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary St Clair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.